Insulin therapy,[1] coupled with advances in continuous glucose monitoring and insulin delivery technologies, has revolutionized the treatment of diabetes, and improved quality of life of patients with diabetes.[2] Continuous glucose monitoring allowed dynamic, highly time‐resolved measurement of blood glucose; however, these measures do not quantify the hormones that stabilize it like glucagon and insulin. Here, INS is linked to diabetes mellitus.